1,854
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Pan-cancer analysis indicates that MYBL2 is associated with the prognosis and immunotherapy of multiple cancers as an oncogene

, , , , , & show all
Pages 2291-2308 | Received 21 Jul 2021, Accepted 14 Sep 2021, Published online: 29 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Hao Wang, Lijun Wang & Gengyun Sun. (2023) MiRNA and Potential Prognostic Value in Non-Smoking Females with Lung Adenocarcinoma by High-Throughput Sequencing. International Journal of General Medicine 16, pages 683-696.
Read now
Meng Jiao, Facai Zhang, Wei Teng & Chengjun Zhou. (2022) MYBL2 is a Novel Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Prostate Cancer. International Journal of General Medicine 15, pages 3003-3030.
Read now

Articles from other publishers (1)

Hye Eun Byeon, Seokjin Haam, Jae Ho Han, Hyun Woo Lee & Young Wha Koh. (2022) Intrinsic and Extrinsic Transcriptional Profiles That Affect the Clinical Response to PD-1 Inhibitors in Patients with Non–Small Cell Lung Cancer. Cancers 15:1, pages 197.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.